Question 1

Does Swiss Life Asset Management own IOVA stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Swiss Life Asset Management holds 21,631 shares of IOVA (Iovance Biotherapeutics), worth $320,571.

Question 2

How many shares of IOVA does Swiss Life Asset Management own?

Accepted Answer

As of its Q3 2026 13F, Swiss Life Asset Management holds 21,631 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is Swiss Life Asset Management's IOVA position worth?

Accepted Answer

As of its Q3 2026 13F, Swiss Life Asset Management's IOVA position is worth $320,571.

Question 4

Is Swiss Life Asset Management buying or selling IOVA?

Accepted Answer

In Q3 2026, Swiss Life Asset Management increased its IOVA position by 1,545 shares (+7.7%).

Question 5

When did Swiss Life Asset Management first buy IOVA?

Accepted Answer

Swiss Life Asset Management first reported IOVA in its Q3 2025 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	21,631	+7.7%	$320,571	0.0%	$14.82	25
2026-Q2	Increased	20,086	+19.9%	$83,558	0.0%	$4.16	25
2026-Q1	Increased	16,754	+26.3%	$58,807	0.0%	$3.51	26
2025-Q4	Increased	13,267	+19.8%	$36,219	0.0%	$2.73	24
2025-Q3	New	11,077	—	$24,037	0.0%	$2.17	26